| Bioactivity | Goxalapladib is a 5-HT6 receptor modulator that blocks lipoprotein-associated phospholipase A2 (Lp-PLA2) activity. Goxalapladib is promising for research of atherosclerosis-associated cardiovascular diseases[1]. |
| CAS | 412950-27-7 |
| Formula | C40H39F5N4O3 |
| Molar Mass | 718.75 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Feuerstein GZ, et al. Discontinued drugs in 2006: cardiovascular drugs translational medicine perspective. Expert Opin Investig Drugs. 2007 Sep;16(9):1315-26. |
Goxalapladib
CAS: 412950-27-7 F: C40H39F5N4O3 W: 718.75
Goxalapladib is a 5-HT6 receptor modulator that blocks lipoprotein-associated phospholipase A2 (Lp-PLA2) activity. Goxal
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.